Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study

SIMPLE SUMMARY: Circulating tumour DNA is a biomarker of significant research interest with a number of randomised controlled trials comparing a ctDNA-informed approach to adjuvant decision making in stage II colon cancer compared to standard of care. However, it is unknown if medical oncologist wou...

Descripción completa

Detalles Bibliográficos
Autores principales: To, Yat Hang, Gibbs, Peter, Tie, Jeanne, Loree, Jonathan, Glyn, Tamara, Degeling, Koen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648421/
https://www.ncbi.nlm.nih.gov/pubmed/37958401
http://dx.doi.org/10.3390/cancers15215227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648421/
https://www.ncbi.nlm.nih.gov/pubmed/37958401
http://dx.doi.org/10.3390/cancers15215227

Ejemplares similares